Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis

Pes Anserinus Tendinobursitis Clinical Trial

Official title:

Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01680263
• Other study ID #: K Homayouni
• Status: Completed
• Phase: N/A
• First received: July 13, 2012
• Last updated: September 3, 2012
• Start date: February 2012
• Est. completion date: July 2012

Study information

• Verified date: September 2012
• Source: Shiraz University of Medical Sciences
• Contact: n/a
• Is FDA regulated: No
• Health authority: Iran: Shiraz University of Medical Sciences
• Study type: Interventional

Clinical Trial Summary

The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis.

Description:

The treatment of pes anserinus tendino-bursitis includes refraining from aggravating activities, local modalities such as heat, ice, ultrasound (US), iontophoresis, phonophoresis, electrical stimulation (ES), nonsteroidal anti-inflammatory drugs (NSAIDs) and injections with either corticosteroids or local anesthetics. Another treatment that seems to have a significant effect on the improvement of the disease is kinesiotaping. Kinesiotaping is a cotton strip with an acrylic adhesive that is used for treating athletic injuries and a variety of physical conditions. The therapeutic effects of the tape is to relax the overused muscles and in rehabilitation to facilitate the underused muscles. Advocates claim that the wave pattern found on the kinesiotaping has a lifting effect on the skin which can diminish swelling and inflammation via improving circulation and reduce pain by removing pressure from pain receptors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: July 2012
• Est. primary completion date: June 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 70 Years

Eligibility

Inclusion Criteria:

• Patients with clinical diagnosis of pes anserinus tendino-bursitis.

Exclusion Criteria:

• Previous history of trauma or surgery on the knee joint,

• History of NSAIDs induced acid-peptic disease

• Systemic and rheumatic diseases

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Bursitis
• Pes Anserinus Tendinobursitis

Intervention

Device:
• Kinesiotaping
Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1week interval

Procedure:
• NSAIDs/Physical therapy
Use of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy.

Locations

Country	Name	City	State
Iran, Islamic Republic of	Shiraz University of Medical Sciences	Shiraz	Fars

Sponsors (1)

Lead Sponsor	Collaborator
Shiraz University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain (VAS)and swelling scores	Visual analog scale for pain evaluation Assessment of the local swelling via palpation	3 weeks	No
Secondary	The number of participants with adverse events	The number of participants with adverse events	3 weeks	Yes